BMP1 Gene Osteogenesis imperfecta type 13 Genetic Test
Test Details
The BMP1 gene is associated with osteogenesis imperfecta type 13, a rare genetic disorder characterized by brittle bones that are prone to fractures. NGS (Next-Generation Sequencing) is a high-throughput sequencing technology that allows for the analysis of multiple genes simultaneously. In the context of genetic testing for osteogenesis imperfecta type 13, NGS can be used to sequence the BMP1 gene to identify any mutations or variations that may be present.
The NGS genetic test for BMP1 gene mutations can help confirm a diagnosis of osteogenesis imperfecta type 13 in individuals with suspected symptoms of the condition. It can also be used for carrier testing in individuals with a family history of the disorder.
Genetic testing can provide valuable information for individuals and families affected by osteogenesis imperfecta type 13, including genetic counseling, management strategies, and potentially targeted treatments in the future. It is important to consult with a healthcare professional or genetic counselor to understand the implications and limitations of the test results.
Test Name
BMP1 Gene Osteogenesis imperfecta type 13 Genetic Test
Components
Price: 4400.0 AED
Sample Condition
Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery
3 to 4 Weeks
Method
NGS Technology
Test type
Osteology Dermatology Immunology Disorders
Doctor
Dermatologist
Test Department
Genetics
Pre Test Information
Clinical History of Patient who is going for BMP1 Gene Osteogenesis imperfecta type 13 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with BMP1 Gene Osteogenesis imperfecta type 13 NGS Genetic DNA Test gene BMP1
For more information or to schedule an appointment, please contact DNA Labs UAE.
Test Name | BMP1 Gene Osteogenesis imperfecta type 13 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Osteology Dermatology Immunology Disorders |
Doctor | Dermatologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for BMP1 Gene Osteogenesis imperfecta type 13 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with BMP1 Gene Osteogenesis imperfecta type 13 NGS Genetic DNA Test gene BMP1 |
Test Details |
The BMP1 gene is associated with osteogenesis imperfecta type 13, a rare genetic disorder characterized by brittle bones that are prone to fractures. NGS (Next-Generation Sequencing) is a high-throughput sequencing technology that allows for the analysis of multiple genes simultaneously. In the context of genetic testing for osteogenesis imperfecta type 13, NGS can be used to sequence the BMP1 gene to identify any mutations or variations that may be present. The NGS genetic test for BMP1 gene mutations can help confirm a diagnosis of osteogenesis imperfecta type 13 in individuals with suspected symptoms of the condition. It can also be used for carrier testing in individuals with a family history of the disorder. Genetic testing can provide valuable information for individuals and families affected by osteogenesis imperfecta type 13, including genetic counseling, management strategies, and potentially targeted treatments in the future. It is important to consult with a healthcare professional or genetic counselor to understand the implications and limitations of the test results. |